Translational Workshop 1: Spatial Omics for Prediction, Prognostication, and Mechanistic Insights
Session Details
This session will highlight advances in spatial omics—including proteomics, metabolomics, and glycomics—for improving prediction, prognostication, and mechanistic understanding in breast cancer, followed by an advocate perspective and panel discussion.
Moderator
Leif W. Ellisen, Mass General Hospital/Harvard Medical School, Boston, MA
Presentation numberWS1-01
Proteomics
Sandro Santagata, Brigham and Women's Hospital, Boston, MA
Presentation numberWS1-02
Metabolomics
Ralph J DeBerardinis, UT Southwestern Medical Center, Dallas, TX
Presentation numberWS1-03
Glycomics
Daniel L. Abravanel, Dana-Farber Cancer Institute, Boston, MA
Advocate
Jane Perlmutter, Gemini Group, Ann Arbor, MI